🟢 HCW Biologics is trading 8% up today as S&P 500 and Nasdaq rise

HCW Biologics is trading at $2.02, up 8.02%, with the move aligned with broader risk-on market sentiment.

• The S&P 500 and Nasdaq are both higher than 0.5%.
• No new company-specific announcement dated September 21, 2026 was identified.
• The latest material release was the September 8 exclusive Akron Biotech distribution agreement for HCW11-006.